Products

Gallium-68 DOTATOC

Gallium-68 DOTATOC

Related Content

NCCN Guidelines Recommend Use of FES PET Imaging for Lobular Breast Cancer
News | PET Imaging
Guidelines Recommend Use of FES PET Imaging for Lobular Breast Cancer

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
GE HealthCare Receives FDA Clearance for Aurora and Clarify DL,
News | Nuclear Imaging
GE HealthCare Receives FDA Clearance for Aurora and Clarify DL

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Prostate Cancer
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
Multi-year supply agreement for radium-226 processing and purification
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
NeuSight PET-CT 3D 64 slice scanner
News | PET-CT
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
Epithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old.
News | PET-CT
Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients with Unresectable Malignant Pleural Mesothelioma

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of the mobile computed tomography (CT) OmniTom Elite with Photon Counting Detector (PCD) technology has received U.S. Food and Drug Administration (FDA) 510(k) clearance
News | Computed Tomography (CT)
NeuroLogica Corp Receives FDA 510(k) Clearance for Enhanced OmniTom Elite with Ultra-High Resolution PCD Technology

July 15, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 15, 2024
arrow
Deal further strengthens Lantheus’ prostate cancer portfolio and expands pipeline to include breast cancer
News | Prostate Cancer
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
The deployment of DL segmentation methods in 18F-fluciclovine PET/CT imaging represents an intriguing research direction for precision medicine in salvage prostate cancer care
News | Prostate Cancer
Deep Learning-assisted Lesion Segmentation in PET/CT Imaging: A Feasibility Study for Salvage Radiation Therapy in Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Vivek S. Kavadi, MD, MBA, FASTRO
News | ASTRO
Dr. Vivek S. Kavadi Named CEO of the American Society for Radiation Oncology (ASTRO)

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now